Mason & Associates »

Biomarin Pharmaceutical shares owned by Mason & Associates

Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by Mason & Associates from 13F filings

Historical chart of Mason & Associates investment in Biomarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharmaceutical held by Mason & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharmaceutical by Mason & Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $13k 13k 1.00

More positions owned by Mason & Associates

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Iron Mountain (IRM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ares Capital Corporation (ARCC)
Broadcom (AVGO)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr Dow Jones Indl Average Ut Ser 1 (DIA)
Honda Motor Adr Ech Cnv In 3 (HMC)
Fidelity Covington Trust High Divid Etf (FDVV)
Dell Technologies CL C (DELL)
Legg Mason Etf Invt Franklin Intl Lw (LVHI)

View all positions for Mason & Associates

Top funds holding Biomarin Pharmaceutical

MacKay Shields
Lazard Asset Management
Wellesley Investment Advisors
Victory Capital Management
iA Global Asset Management
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Thrivent Financial for Lutherans
Shenkman Capital Management
Morgan Stanley
Sonora Investment Management Group
Jpmorgan Chase & Co
Bank of America Corporation
Leucadia National Corporation
Franklin Resources
Wellington Management Company

View all funds holding Biomarin Pharmaceutical